| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/06/2006 | US20060148798 Antiinflammatory agents; cardiovascular disorders; antidiabetic agents;central nervous system diosrders ; anticancer agents |
| 07/06/2006 | US20060148792 Substituted 1,4-benzodiazepines and uses thereof |
| 07/06/2006 | US20060148769 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 07/06/2006 | US20060148751 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 07/06/2006 | US20060148723 Novel glycolipid and medicine for autoimmune disease containing the same as active ingredient |
| 07/06/2006 | US20060148707 Use of ligands to GABA beta receptors |
| 07/06/2006 | US20060148692 Novel protein and its dna |
| 07/06/2006 | US20060148682 Identifying substrate of an enzyme that is secreted by MCF7/6, HepG2, or HT29 cells; covalently attaching by amidation or esterification the substrate to drug to form a prospective tumor-activated prodrug; drug screening and testing; antitumor, antiinflammatory and anticarcinogenic agents; diagnosis |
| 07/06/2006 | US20060148678 Novel acyl-dipeptide-like compounds, a method for preparing the same and pharmaceutical compositions containing such products |
| 07/06/2006 | US20060148060 Biomolecule transduction motif Mph-1-BTM and the use thereof |
| 07/06/2006 | US20060148035 Host cells containing mannosidase catalytic domains within endoplasmic reticulum or Golgi complex for producing glycoproteins with glycan structures attached in glycoform that serve as substrate for transferases |
| 07/06/2006 | US20060148030 Nuclear receptor err y 3 |
| 07/06/2006 | US20060147564 Composition for preventing or treating allergic disease using black rice extract and its therapeutic use |
| 07/06/2006 | US20060147548 Therapeutic delivery of carbon monoxide |
| 07/06/2006 | US20060147462 For diagnostic, prophylactic and therapeutic uses, vaccines against bacterial infections |
| 07/06/2006 | US20060147454 Human serine protease and serpin polypeptides |
| 07/06/2006 | US20060147446 Humanized antibodies to human GP39, compositions, and therapeutic uses thereof |
| 07/06/2006 | US20060147437 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/06/2006 | US20060147434 Different dendritic cell subsets |
| 07/06/2006 | US20060147432 Tolerogenic antigen-presenting cells |
| 07/06/2006 | US20060147417 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use |
| 07/06/2006 | US20060146644 System for producing micro-cluster liquids |
| 07/06/2006 | CA2594325A1 Condensed imidazole compound and use thereof |
| 07/06/2006 | CA2594280A1 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists |
| 07/06/2006 | CA2594241A1 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment |
| 07/06/2006 | CA2593035A1 Pharmaceutical compositions for treating diseases associated with nf-.kappa.b activity |
| 07/06/2006 | CA2591912A1 Pyrimidinylisoxazole derivatives |
| 07/06/2006 | CA2590961A1 [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases |
| 07/06/2006 | CA2590681A1 N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid cb1 receptor antagonists |
| 07/05/2006 | EP1676920A2 Anticoagulant fusion protein anchored to cell membrane |
| 07/05/2006 | EP1676918A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 07/05/2006 | EP1676912A2 Medical equipment containing a polypeptide having heparanase activity |
| 07/05/2006 | EP1676908A1 Fermentation and culture method, fermented plant extract, fermented plant extract powder and composition containing the fermented plant extract |
| 07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
| 07/05/2006 | EP1676580A1 Glycyrrhizin high-concentration preparation |
| 07/05/2006 | EP1676574A2 Methods for promoting survival of transplanted tissues and cells |
| 07/05/2006 | EP1675834A1 Compounds, compositions, and methods |
| 07/05/2006 | EP1675652A2 Treatment of ocular disease |
| 07/05/2006 | EP1675615A1 Treatment of respiratory diseases with anti-il-2 receptor antibodies |
| 07/05/2006 | EP1675605A1 Pharmaceutical composition which can be used, for example, as an antiviral or antibacterial agent and to stimulate immune defences |
| 07/05/2006 | EP1675547A2 Glucocerebroside treatment of disease |
| 07/05/2006 | EP1418881A4 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 07/05/2006 | EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/05/2006 | EP1390049B1 Compositions for treating animal diseases and syndromes comprising transfer factor |
| 07/05/2006 | EP1274853B1 Materials and methods relating to immune responses to fusion proteins |
| 07/05/2006 | EP1214344B1 Dipeptidyl peptidases |
| 07/05/2006 | EP1161250B9 Immunostimulant bacterial membrane fractions in cancer treatment |
| 07/05/2006 | EP1105485B1 Human il-1 epsilon dna and polypeptides |
| 07/05/2006 | EP0879289B1 Human dnase resistant to actin inhibition |
| 07/05/2006 | EP0702725B1 Method for recombinant production of biologically active polypeptides |
| 07/05/2006 | CN1798975A Method of screening drug with the use of 67 KDA laminin receptor and drug obtained thereby |
| 07/05/2006 | CN1798834A Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclon |
| 07/05/2006 | CN1798769A Antibodies to masp-2 |
| 07/05/2006 | CN1798728A Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 07/05/2006 | CN1798577A Method of inducing differentiation and proliferating regulatory t cell by anti-CD52 antibody and medicinal composition therefor |
| 07/05/2006 | CN1798563A Immunostimulant |
| 07/05/2006 | CN1796558A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 07/05/2006 | CN1796418A Immune polysaccharide of rhizome of manyflower solomonseal, composition and application |
| 07/05/2006 | CN1795891A Composite of total flavone phosphatide of astragalus, and preparation method |
| 07/05/2006 | CN1795888A Application of Extractive of Abarema elliptica in use for preparing antiallergic medication, food and cosmetic |
| 07/05/2006 | CN1795882A Medicine application of catalpa and extractive for anti allergic disease |
| 07/05/2006 | CN1795877A Ganoderma lucidum capsule of lycopene |
| 07/05/2006 | CN1795866A Complex of total flavone phospholipid of blackberry lily and preparation method |
| 07/05/2006 | CN1795860A Oral taking chewy composition for covering unflavored taste and preparation method |
| 07/05/2006 | CN1795760A Nutrition powder for prolonging life and enhancing the body resistance |
| 07/05/2006 | CN1262668C Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 07/05/2006 | CN1262561C Synthetic poly peptide disturbing intracelluler signaling |
| 07/05/2006 | CN1262541C Tricyclic protein kinase inhibitors |
| 07/05/2006 | CN1262306C Medicine tea with function of raising immunity, resisting fatigue and preventing impotence and prospermia |
| 07/05/2006 | CN1262295C Health care medicine capable of strengthening heart and kidney function and immunologic function |
| 07/05/2006 | CN1262210C Health-care food |
| 07/04/2006 | US7071355 Enzyme inhibitors; anticancer agents; autoimmune diseases; antiprotozoa agents; viricides |
| 07/04/2006 | US7071344 Vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 07/04/2006 | US7071332 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 07/04/2006 | US7071222 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and N-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide |
| 07/04/2006 | US7071213 Cannabinoid receptor ligands |
| 07/04/2006 | US7071202 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 07/04/2006 | US7071191 Non-imidazole aryloxypiperidines |
| 07/04/2006 | US7071183 Use of inhibitors of the renin-angiotensin system |
| 07/04/2006 | US7071179 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 07/04/2006 | US7071178 Bone disorders; osteoporosis |
| 07/04/2006 | US7071177 P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents |
| 07/04/2006 | US7070977 Human serine protease D-G polypeptide |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | US7070814 Plant extracts for treatment of cancer |
| 07/04/2006 | US7070771 Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells |
| 07/04/2006 | US7070766 Delivery of physiologically active compounds through an inhalation route |
| 07/04/2006 | US7070765 condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing the vapor; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns. |
| 07/04/2006 | US7070764 Delivery of analgesics through an inhalation route |
| 07/04/2006 | US7070763 Delivery of diphenhydramine through an inhalation route |
| 07/04/2006 | US7070762 Delivery of analgesics through an inhalation route |
| 07/04/2006 | US7070761 Aerosols; heating, vaporization, cooling |
| 07/04/2006 | CA2264721C A1 adenosine receptor antagonists |
| 07/04/2006 | CA2233285C Pyrazolopyrimidines as crf receptor antagonists |
| 06/29/2006 | WO2006069202A2 Compositions comprising anti-igf-i receptor antibodies and methods for obtaining said antibodies |
| 06/29/2006 | WO2006068770A1 Spiro-2, 4-pyrimidinediamine compounds and their uses |
| 06/29/2006 | WO2006068199A1 Metabolically stable 3-oxy-1,2,4-triazole derivatives |
| 06/29/2006 | WO2006068058A1 Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine |
| 06/29/2006 | WO2006067920A1 Pharmaceutical for bone marrow stem cell transplantation therapy |
| 06/29/2006 | WO2006067913A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |